Stabilux Biosciences
Ann Arbor, US · Michigan corporation · 2 known investors
Founders & leadership
JL
JONATHAN LEINONENNamed on SEC filing
YK
YOKE KHIN YAPNamed on SEC filing
MM
MICHAEL MORTLOCKNamed on SEC filing
ME
MARK EHLERTNamed on SEC filing
ST
STEVE TOKARZNamed on SEC filing
JR
JOHN RANSOMNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$554.4K disclosed across 1 round · 2024
▶$554.4KraisedMay 2024 · 9 investors · BiotechnologyRule 506(b)
▶$554.4KraisedMay 2024 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JONATHAN LEINONENExecutive Officer, Director
- YOKE KHIN YAPExecutive Officer, Director
- MICHAEL MORTLOCKExecutive Officer
- MARK EHLERTDirector
- STEVE TOKARZExecutive Officer, Director
- JOHN RANSOMDirector
- Offering amount
- $3M
- Amount sold
- $554.4K
- Proceeds to insiders
- $250K
- First sale
- Apr 2024
- Incorporated
- Corporation, Michigan
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Stabilux Biosciences's investors?
- Stabilux Biosciences's investors include ID Ventures, Invest Michigan.
- How much funding has Stabilux Biosciences raised?
- Stabilux Biosciences has disclosed $554.4K raised across 1 round.
- Where is Stabilux Biosciences headquartered?
- Stabilux Biosciences is headquartered in Ann Arbor, US.